Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Monaco

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Hematology & Oncology|April 14, 2016
A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patientsCinzia Pellegrini, Anna Dodero, Annalisa Chiappella, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2016
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell TransplantationAlessandro Busca, Anna Candoni, Ernesta Audisio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 9, 2016
A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host DiseaseFrancesco Zallio, Laura Mazzucco, Federico Monaco, et al.
Science (New York, N.Y.)|April 28, 2022
Dynamics of particle network in composite battery cathodesJizhou Li, Nikhil Sharma, Zhisen Jiang, et al.
Journal of Basic and Clinical Physiology and Pharmacology|April 11, 2023
The role of Bruton's kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinibGioacchino Catania, Rita Tavarozzi, Giacomo Maria Pini, et al.
Cancers|November 25, 2023
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical PracticeRita Tavarozzi, Giulia Zacchi, Daniela Pietrasanta, et al.
Haematologica|January 12, 2019
Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasmsFederico Monaco, Bart L Scott, Thomas R Chauncey, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2019
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life ExperienceMiriam Marangon, Vittorio Stefoni, Alessia Castellino, et al.
Thrombosis and Haemostasis|April 28, 2017
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL)Roberto Mario Santi, Manuela Ceccarelli, Elisa Bernocco, et al.
Leukemia & Lymphoma|January 7, 2016
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient programPier Luigi Zinzani, Cinzia Pellegrini, Giuseppe Cerciello, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Hematology & Oncology|April 14, 2016
A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patientsCinzia Pellegrini, Anna Dodero, Annalisa Chiappella, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 27, 2016
Long-Lasting Protective Effect of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell TransplantationAlessandro Busca, Anna Candoni, Ernesta Audisio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 9, 2016
A Single-Center Pilot Prospective Study of Topical Application of Platelet-Derived Eye Drops for Patients with Ocular Chronic Graft-versus-Host DiseaseFrancesco Zallio, Laura Mazzucco, Federico Monaco, et al.
Science (New York, N.Y.)|April 28, 2022
Dynamics of particle network in composite battery cathodesJizhou Li, Nikhil Sharma, Zhisen Jiang, et al.
Journal of Basic and Clinical Physiology and Pharmacology|April 11, 2023
The role of Bruton's kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinibGioacchino Catania, Rita Tavarozzi, Giacomo Maria Pini, et al.
Cancers|November 25, 2023
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical PracticeRita Tavarozzi, Giulia Zacchi, Daniela Pietrasanta, et al.
Haematologica|January 12, 2019
Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasmsFederico Monaco, Bart L Scott, Thomas R Chauncey, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 14, 2019
Lenalidomide Combination Therapy in Relapsed/Refractory Diffuse Large B Cell Lymphoma: The Italian Real-Life ExperienceMiriam Marangon, Vittorio Stefoni, Alessia Castellino, et al.
Thrombosis and Haemostasis|April 28, 2017
Khorana score and histotype predicts incidence of early venous thromboembolism in non-Hodgkin lymphomas. A pooled-data analysis of 12 clinical trials of Fondazione Italiana Linfomi (FIL)Roberto Mario Santi, Manuela Ceccarelli, Elisa Bernocco, et al.
Leukemia & Lymphoma|January 7, 2016
Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient programPier Luigi Zinzani, Cinzia Pellegrini, Giuseppe Cerciello, et al.
Pageof 3